The global respiratory syncytial virus RSV therapeutics market was valued at approximately US$ 820.0 Mn in 2016 is projected to expand at a CAGR of more than 11.0% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Respiratory Syncytial Virus Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.
July 25, 2022
· 7 min read